KRAS and non-small cell lung carcinoma: A Co-IP analysis demonstrated an endogenous interaction between PSAT1 and PKM2 in two separate NSCLC cell systems, KRAS-mutant A549 cells and EGFR-mutant PC9 cells (Figure 3A).